Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Himanshu Dhamankar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Structural Biology|May 24, 2011
Microbial chemical factories: recent advances in pathway engineering for synthesis of value added chemicalsHimanshu Dhamankar, Kristala L J Prather
Metabolic Engineering|June 24, 2014
Engineering E. coli for the biosynthesis of 3-hydroxy-γ-butyrolactone (3HBL) and 3,4-dihydroxybutyric acid (3,4-DHBA) as value-added chemicals from glucose as a sole carbon sourceHimanshu Dhamankar, Yekaterina Tarasova, Collin H Martin, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 10, 2011
Electrospray as a tool for drug micro- and nanoparticle patterningElke Scholten, Himanshu Dhamankar, Lev Bromberg, et al.
Nature Communications|January 31, 2013
A platform pathway for production of 3-hydroxyacids provides a biosynthetic route to 3-hydroxy-γ-butyrolactoneCollin H Martin, Himanshu Dhamankar, Hsien-Chung Tseng, et al.
Scientific Reports|December 1, 2023
Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal modelsFelipe Lelis, Laura A Byk, Sergei Pustylnikov, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Structural Biology|May 24, 2011
Microbial chemical factories: recent advances in pathway engineering for synthesis of value added chemicalsHimanshu Dhamankar, Kristala L J Prather
Metabolic Engineering|June 24, 2014
Engineering E. coli for the biosynthesis of 3-hydroxy-γ-butyrolactone (3HBL) and 3,4-dihydroxybutyric acid (3,4-DHBA) as value-added chemicals from glucose as a sole carbon sourceHimanshu Dhamankar, Yekaterina Tarasova, Collin H Martin, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 10, 2011
Electrospray as a tool for drug micro- and nanoparticle patterningElke Scholten, Himanshu Dhamankar, Lev Bromberg, et al.
Nature Communications|January 31, 2013
A platform pathway for production of 3-hydroxyacids provides a biosynthetic route to 3-hydroxy-γ-butyrolactoneCollin H Martin, Himanshu Dhamankar, Hsien-Chung Tseng, et al.
Scientific Reports|December 1, 2023
Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal modelsFelipe Lelis, Laura A Byk, Sergei Pustylnikov, et al.
Pageof 1